4th Quarter - Report

THE GIBSON GROUP, LLC for ENDO PHARMACEUTICALS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Oversight of implementation of the America Invents Act.

LobbyistCovered position, as disclosed
JOSEPH H GIBSON —

Contacted: HOUSE OF REPRESENTATIVES

Government Issues GOV

H.R. 3010 - Regulatory Accountability Act of 2011.

LobbyistCovered position, as disclosed
JOSEPH H GIBSON —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 3010 (112th)

Health Issues HCR

S. 319 - Pharmaceutical Market Access and Drug Safety Act of 2011. H.R. 3988 - Generic Drug and Biosimilar User Fee Act of 2012. S. 3187 - Food and Drug Administration Safety and Innovation Act. Issues relating to bioequivalence and related administrative procedures. Issues relating to DEA quotas for controlled substances. Oversight of DEA. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations.

LobbyistCovered position, as disclosed
JOSEPH H GIBSON Counsel, House Judiciary Comm. '95-'97

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 3988 (112th), S. 319 (112th), S. 3187 (112th)

Taxation/Internal Revenue Code TAX

H.R. 2632 - Life Sciences Jobs and Investment Act of 2011.

LobbyistCovered position, as disclosed
JOSEPH H GIBSON —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 2632 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.